Skip to search formSkip to main contentSkip to account menu

5 ML dinutuximab 3.5 MG/ML Injection [Unituxin]

Known as: DINUTUXIMAB 3.5 mg in 1 mL INTRAVENOUS INJECTION [Unituxin], 5 ML Unituxin 3.5 MG/ML Injection, Unituxin 17.5 MG in 5 ML Injection 
National Institutes of Health

Related topics

Related topics

9 relations
HistidineHydrochloric AcidInjectionPolysorbate 20

Broader (1)

Unituxin Injectable Product

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Dinutuximab: A Review in High-Risk Neuroblastoma
Dinutuximab (ch14.18; Unituxin™) is a chimeric human–mouse monoclonal antibody that binds to the glycolipid antigen… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)